betadex and Neuroendocrine-Tumors

betadex has been researched along with Neuroendocrine-Tumors* in 1 studies

Other Studies

1 other study(ies) available for betadex and Neuroendocrine-Tumors

Article	Year
A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease. International journal of pharmaceutics, 2017, Mar-15, Volume: 519, Issue:1-2 Two [19F]F-l-DOPA (F-DOPA) new β-cyclodextrin (CD)-based dosage forms (FA and FB, respectively) have been studied and their physico-chemical and pharmacological features determined to overcome the administration site reactions showed by the currently used [18F]F-l-DOPA formulation (IASOdopa Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Neuroblastoma; Neuroendocrine Tumors; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar	2017

Article

Year

A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease.

International journal of pharmaceutics, 2017, Mar-15, Volume: 519, Issue:1-2

Two [19F]F-l-DOPA (F-DOPA) new β-cyclodextrin (CD)-based dosage forms (FA and FB, respectively) have been studied and their physico-chemical and pharmacological features determined to overcome the administration site reactions showed by the currently used [18F]F-l-DOPA formulation (IASOdopa

Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Neuroblastoma; Neuroendocrine Tumors; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar

2017